use of an inhibitor of the tyrosine kinase c-abl, pdgf-r and c-kit in the treatment of diabetes

摘要

The invention relates to the use of tyrosine kinase c-Abl inhibitor. PDGF-R or c-kit--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- II